For research use only
| Cat No. | ABC-H0014X |
| Product Type | Blood Products |
| Cell Type | Osteoclast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Osteoclast Precursor Cells are cryopreserved, TRAP-positive, and support osteoclast differentiation studies for bone and resorption research.
Human Osteoclast Precursor Cells (OCPs) are primary mononuclear cells derived from peripheral blood, bone marrow, or umbilical cord blood of healthy human donors. These cells are precursors to multinucleated osteoclasts and are implicated in bone-resorptive diseases such as osteoporosis, rheumatoid arthritis, and multiple myeloma. Following isolation, they are cryopreserved and typically not passaged due to their limited proliferative capacity. These cells represent an early stage in the osteoclast lineage and exhibit a round or slightly irregular morphology. Functionally, These precursors express markers such as CD11b, CD14, CD115, tartrate-resistant acid phosphatase (TRAP), cathepsin K, RANK, and NFATc1, with CD16⁺ subsets showing heightened osteoclastogenic potential in inflammatory conditions. Their differentiation is RANKL-dependent, making them powerful models for studying bone metabolism disorders.
| Product Code | Human Osteoclast Precursor Cells, Osteoclast Progenitors, hOCPs, Monocyte Derived Osteoclast Precursors, Pre-Osteoclasts |
| Species | Human |
| Cat.No | ABC-H0014X |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Osteoclast |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Osteoclast Precursor Cells (OCPs) have versatile applications, particularly in high-throughput studies focused on osteoporosis, bone resorption, and related disorders. They provide valuable insights into how environmental factors affect osteoclast formation and contribute to disease pathogenesis. Additionally, these cells enable detailed investigation of key regulators—such as chemokines and macrophage colony-stimulating factor (M-CSF)—that influence the recruitment of osteoclast precursors to bone tissue. Improved understanding of OCP heterogeneity, behavior, and recruitment mechanisms offers promising avenues for developing targeted therapies aimed specifically at osteoclast-related conditions.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).